TY  -  
T1  - CD34+ cell mobilization, blood graft composition, and posttransplant recovery in myeloma patients compared to non-Hodgkinʼs lymphoma patients: results of the prospective multicenter Goa study 
SN  -  /  
UR  - http://hdl.handle.net/10138/318029 
T3  -  
A1  - Turunen, Antti; Partanen, Anu; Valtola, Jaakko; Ropponen, Antti; Siitonen, Timo; Kuittinen, Outi; Kuitunen, Hanne; Putkonen, Mervi; Sankelo, Marja; Keskinen, Leena; Savolainen, Eeva-Riitta; Pyörälä, Marja; Kuittinen, Taru; Silvennoinen, Raija; Penttilä, Karri; Sikiö, Anu; Vasala, Kaija; Mäntymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville; Jantunen, Esa 
A2  -  
PB  -  
Y1  - 2020 
LA  - eng 
AB  - BACKGROUND Autologous stem cell transplantation is an established treatment option for patients with multiple myeloma (MM) or non-Hodgkin?s lymphoma (NHL). STUDY DESIGN AND METHODS In this prospective multicenter study, 147 patients with MM were compared with 136 patients with NHL regarding the mobilization and apheresis of blood CD34+ cells, cellular composition of infused blood grafts, posttransplant recovery, and outcome. RESULTS Multiple myeloma patients mobilized CD34+ cells more effectivel... 
VO  -  
IS  -  
SP  -  
OP  -  
KW  - 3126 Surgery, anesthesiology, intensive care, radiology; STEM-CELL TRANSPLANTATION; PLUS G-CSF; HEMATOPOIETIC STEM; POOR MOBILIZATION; RISK-FACTORS; CYCLOPHOSPHAMIDE; MORTALITY; IMPACT; VOLUME; PLERIXAFOR; 3122 Cancers 
N1  -   
PP  -  
ER  -